scholarly journals Knowledge of Validation Status of Point-of-care Glucometers among Veterinarians and Veterinary Technologists in Nigeria

2021 ◽  
Vol 41 (3) ◽  
pp. 214-222
Author(s):  
C.O Okorie-Kanu ◽  
O.J Okorie-Kanu ◽  
C.A Akwuobu ◽  
E.V Tizhe ◽  
R.E Antia

Point-of-care glucometers (PCGs) have of recent almost replaced the conventional laboratory methods of blood glucose determination in animals. This study evaluated the level of awareness and knowledge about the use of handheld PCGs among veterinarians and veterinary technologists. Respondents to a structured questionnaire included academic staff and laboratory technologists from veterinary schools and public and private veterinarians across Nigeria. Design of the questions progressed from whether one had ever used a PCG before or not, how they knew about the PCG, the brands used, for what purposes and on which animals. Results showed that out of 209 respondents, 75 (36%) had used PCGs. Of this number, 37 (49.33%) used PCGs for research purposes, while 36 and 6.67% had used the PCGs for diagnosis of glucose disorders in animals and for both research and diagnostic purposes, respectively. The distribution of respondents that knew about the validation status of the PCGs used was 2.67%. As values generated by each PCG vary significantly in different species, there may be chances of reporting erroneous research conclusions as well as misdiagnosis of glucose disorders with consequent erroneous therapies in such species. Keywords: Point-of-care Glucometers, Validation status, Veterinarians.

2011 ◽  
Vol 31 (9) ◽  
pp. 0900105
Author(s):  
陈星旦 Chen Xingdan ◽  
王动民 Wang Dongmin ◽  
卢启鹏 Lu Qipeng ◽  
丁海泉 Ding Haiquan

2020 ◽  
Author(s):  
Lei Zhang ◽  
Yaqiong Ran ◽  
Yan Zhu ◽  
Qianna Zhen

Abstract Objective Sodium fluoride (NaF) has been applied to inhibit glycolysis in venous specimens for decades. However, it has had little effect on the rate of glycolysis in the first 1 to 2 hours, resulting in a decrease of glucose, so a more efficient method is needed. Recently, we discovered that WZB117, a specific Glut1 inhibitor, restricts glycolysis by inhibiting the passive sugar transport of human red blood cells and cancer cells. The purpose of this study was to evaluate the results of intravenous blood glucose determination after the addition of WZB117. Methods Venous specimens from 40 pairs of healthy volunteers were collected for several days and placed in tubes containing NaF plus EDTA-disodium (Na2) without WZB117 (the A group); citric acid, trisodium citrate, and EDTA-Na2 without WZB117 (B group); and NaF plus EDTA-Na2 with WZB117 (C group). The glucose concentration was measured after venipuncture and compared with test tubes treated for 1 hour, 2 hours, and 3 hours before centrifugation. Glucose level was determined by the hexokinase method. The paired t-test was used to examine differences in glucose values at baseline and at different time points. The number of misdiagnoses and the misdiagnosis rate were calculated at 2 diagnostic stages: high risk of diabetes (glucose level of 6.1 mmol/L) and diagnosis of diabetes (glucose level of 7.0 mmol/L). Results Glucose levels decreased by 1.0% at 1 hour and by 2.1% at 3 hours in the C group tubes and simultaneously decreased by 1.7% at 1 hour and by 2.5% at 3 hours in the B group tubes. In contrast, glucose levels decreased by 4.1% at 1 hour and by 6.3% at 3 hours in the A group tubes. There was a statistically significant difference in glucose levels measured in the A group tubes and B group tubes at 1 hour, 2 hours, and 3 hours. The misdiagnosis rate of clinical diagnosis in diabetes was highest in the A group tubes (7.0‰ at 1 hour, 0.1‰ at 3 hours at 7.0 mmol/L point; 14.6‰ at 1 hour, 0.4‰ at 3 hours at 6.1 mmol/L point) and lowest in the C group tubes (2.95‰ at 1 hour, 0‰ at 3 hours at 7.0 mmol/L point; 4.8‰ at 1 hour, 0.1‰ at 3 hours at 6.1 mmol/L point). Conclusion The tube addition of WZB117 is more suitable for minimizing glycolysis and has no effect on glucose levels even if specimens are left uncentrifuged for up to 3 hours.


1971 ◽  
Vol 17 (5) ◽  
pp. 440-441 ◽  
Author(s):  
Giovanni Ceriotti

Abstract A method is described for determining glucose in 25 µl of plasma. o-Toluidine is used in weak acetic acid solution. Addition of the emulsifier "Cremophor" obviates the need for deproteinization. The reaction is complete after 15 min at 100°C, and the color is stable for longer than 24 h. The blank is almost colorless. The reagent is stable, colorless, not viscous, and convenient to handle.


1997 ◽  
Vol 359 (1) ◽  
pp. 78-82 ◽  
Author(s):  
C. Fischbacher ◽  
K.-U. Jagemann ◽  
K. Danzer ◽  
U. A. Müller ◽  
L. Papenkordt ◽  
...  

The Lancet ◽  
1985 ◽  
Vol 325 (8424) ◽  
pp. 341 ◽  
Author(s):  
E. Sanders ◽  
M. Deadman

Sign in / Sign up

Export Citation Format

Share Document